
Hypertensive disorders remain a leading cause of maternal and perinatal morbidity worldwide. This accredited continuing professional development (CPD) convenes leading obstetricians, physicians, pharmacists, midwives and nurses to examine the latest evidence-based strategies for preventing, diagnosing and treating hypertension in pregnancy. Delivered in a dynamic hybrid format, the meeting blends live plenary teaching, real-time discussion and a focused product presentation introducing Ethypharm’s Magnesium Sulphate—a critical intervention in the management of severe gestational hypertension and eclampsia.
Participants will engage with a distinguished, multidisciplinary faculty who will translate cutting-edge research into practical bedside interventions, ensuring attendees leave equipped to improve maternal and neonatal outcomes in their own settings.
WHY YOU SHOULD ATTEND
i. Immediate clinical relevance – Gain concrete, guideline-aligned approaches you can apply on your next ward round or antenatal clinic.
ii. Earn CPD credits – Satisfy annual professional‐development requirements through an event vetted and accredited by the relevant councils.
iii. Product insight – Be among the first to explore Ethypharm’s enhanced Magnesium Sulphate formulation and discuss its role in current treatment algorithms.
iv. Interactive learning – Case vignettes, polling and Q&A ensure active participation, whether you join in person or online.
v. Network across cadres – Forge vital connections with consultants, residents, pharmacists, midwives and policy makers committed to maternal safety.
EVENT HIGHLIGHTS
1. Keynote Session: “Enhancing Maternal Care—Best Practices in Managing Hypertensive Disorders During Pregnancy”
2. Product Launch: Official unveiling of Ethypharm Magnesium Sulphate with formulation data, dosing guidance and safety profile
3. Multidisciplinary Panel: Obstetric physicians, clinical pharmacists and midwifery leaders debate real-world challenges and innovations
4. Case-Based Workshops: Interactive scenarios on triage, stabilization and magnesium-sulphate administration in resource-variable settings
5. Hybrid Delivery: High-definition live-stream, on-demand replay and in-hall engagement tools for seamless participation
6. Accredited Certificate: Digital CPD certificate issued upon completion of post-event assessment and feedback
Secure your seat—whether on-site or online—and join us for an unmissable day devoted to safeguarding mothers and babies through excellence in hypertensive care.
PROUDLY ORGANIZED AND SPONSORED BY
This is a hybrid event that will take place on Thursday the 5th of June 2025 at 4:00 pm. It will be streamed live on this page.
Target Audience: Obstetricians & gynaecologists (consultants, specialists, residents), general medical practitioners, midwives, nurses, clinical pharmacists, and allied maternity-care professionals.
Moderator: Raymond Otu-Amanortey - Ethypharm Ghana
Date: Thursday 5th June 2025
Time: 1600 GMT (4:00 pm local time)
AGENDA
Thursday 5th June 2025 (HYBRID EVENT)
4:00 pm – 4:30 pm: Arrival of Guests
4:30 pm – 4:40 pm: Welcome Address by Raymond Otu Amanortey (Country Manager Ethypharm, Ghana)
4:40 pm – 4:50 pm: Ethypharm Introductory Video - Media Team
4:55 pm – 5:40 pm: Enhancing Maternal Care: Best Practices in Managing Hypertensive Disorders During Pregnancy by Dr. Promise Emmanuel Sefogah
5:40 pm – 6:00 pm: Unveiling the Ethypharm brand of Magnesium sulphate and product presentation Questions and Answers by Raymond Otu Amanortey
6:00 pm – 6:30 pm: Questions & Answers – All
6:30 pm – 6:35 pm: Closing Remarks by Raymond Otu Amanortey (Country Manager Ethypharm, Ghana)
6:35 pm Onwards: Dinner - All
In-person attendance is STRICTLY BY INVITATION at the Holiday Inn Accra Airport
This CPD-accredited hybrid symposium brings together obstetricians, physicians, pharmacists, midwives and nurses to examine the latest evidence-based strategies for diagnosing and managing hypertensive disorders in pregnancy, while simultaneously unveiling Ethypharm’s new formulation of magnesium sulphate. Guided by an expert multidisciplinary faculty, participants will engage in interactive plenaries, case-based discussions and product-focused insights that translate cutting-edge research into practical bedside interventions, ultimately equipping them to improve maternal and neonatal outcomes in their own clinical settings.
By the end of the symposium, participants will be able to:
1. Describe the epidemiology, pathophysiology and classification of hypertensive disorders of pregnancy, including gestational hypertension, pre-eclampsia and eclampsia.
2. Apply current international and national guidelines to diagnose and stratify risk in pregnant patients presenting with hypertension.
3. Formulate individualized management plans integrating lifestyle modification, pharmacotherapy and timely referral or escalation of care.
4. Demonstrate correct dosing, administration and monitoring of Magnesium Sulphate, recognising indications, contraindications and adverse-event management.
5. Evaluate emerging evidence on adjunct therapies and biomarkers aimed at improving maternal and fetal outcomes.
6. Collaborate effectively within multidisciplinary teams to implement quality-improvement initiatives that reduce maternal mortality and morbidity related to hypertension.
BSc, MBChB, DLSHTM, MPH, MGCS, FMAS, FWACS
Senior Lecturer | Consultant Obstetrician Gynaecologist | Medical Director
Department of Obstetrics and Gynaecology, University of Ghana Medical School
Korle Bu Teaching Hospital
SHAPE Healthcare Specialist Medical Center
Dr. Promise Emmanuel Sefogah graduated with the Class of 2004 from the University of Ghana Medical School. He pursued his postgraduate training in Obstetrics and Gynaecology at the Ghana College of Physicians & Surgeons, and the West African College of Surgeons from where he obtained his fellowship.
View full profile / courses